Brief: Rani Therapeutics Holdings Inc - Capitalized To Fund Operations Into Mid-2024
10/08/2022 21:56
Aug 10 (Reuters) - Rani Therapeutics Holdings Inc RANI.O :
* RANI THERAPEUTICS HOLDINGS INC - CAPITALIZED TO FUND
OPERATIONS
INTO MID-2024
* RANI THERAPEUTICS HOLDINGS INC - QTRLY NET LOSS PER CLASS
A
COMMON SHARE $0.31
Further company coverage: RANI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rani Therapeutics Holdings
See all newsRani Therapeutics Q2 net loss narrows as revenue rises helped by Chugai agreement
Brief: Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Pegbio Co Enters MoU With Rani Therapeutics
Brief: Rani Therapeutics Announces R&D Collaboration With PegBio
Rani Therapeutics Q1 contract revenue rises on Chugai collaboration; announces CFO transition